Sex and gender differences in chronic kidney disease: Progression to end-stage renal disease and haemodialysis

Clinical Science

Volumn 130, Issue 14, 2016, Pages 1147-1163

  Cobo, Gabriela ^a   Hecking, Manfred ^b   Port, Friedrich K ^c   Exner, Isabella ^d   Lindholm, Bengt ^a   Stenvinkel, Peter ^a   Carrero, Juan Jesús ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

^c ARBOR RESEARCH COLLABORATIVE FOR HEALTH   (United States)

^d First Medical Department   (Austria)

Author keywords

Anaemia; Dialysis; Gender medicine; Inequalities; Oestrogen; Sex; Testosterone

Indexed keywords

ESTROGEN; NITRIC OXIDE; PROLACTIN; TESTOSTERONE;

ANEMIA; BONE DISEASE; CHRONIC KIDNEY FAILURE; CLINICAL DECISION MAKING; DIALYSIS; DISEASE COURSE; END STAGE RENAL DISEASE; ESTIMATED GLOMERULAR FILTRATION RATE; FEMALE; GONAD; HEMODIALYSIS; HUMAN; KIDNEY FUNCTION; LIFESTYLE; MALE; NEPHROLOGY; OXIDATIVE STRESS; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; RANDOMIZED CONTROLLED TRIAL (TOPIC); RENAL REPLACEMENT THERAPY; REVIEW; SEX DIFFERENCE; SOCIAL PSYCHOLOGY; SOCIOECONOMICS; COMPLICATION; GLOMERULUS FILTRATION RATE; KIDNEY; KIDNEY FAILURE, CHRONIC; METABOLISM; PHYSIOLOGY; SEXUAL DEVELOPMENT;

DISEASE PROGRESSION; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY; KIDNEY FAILURE, CHRONIC; MALE; NITRIC OXIDE; OXIDATIVE STRESS; PROLACTIN; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RENAL DIALYSIS; RENAL INSUFFICIENCY, CHRONIC; SEX CHARACTERISTICS; SOCIOECONOMIC FACTORS;

EID: 85014069286     PISSN: 01435221     EISSN: 14708736     Source Type: Journal    
DOI: 10.1042/CS20160047     Document Type: Review

References (225)

1. Carrero, J.J. (2010) Gender differences in chronic kidney disease: underpinnings and therapeutic implications. Kid. Blood Press. Res. 33, 383-392
2. Mosca, L., Barrett-Connor, E. and Wenger, N.K. (2011) Sex/gender differences in cardiovascular disease prevention: what a difference a decade makes. Circulation 124, 2145-2154
3. Mazure, C.M. and Jones, D.P. (2015) Twenty years and still counting: including women as participants and studying sex and gender in biomedical research. BMC Womens Health 15, 94
4. Hennekens, C.H. and Eberlein, K. (1985) A randomized trial of aspirin and beta-carotene among U. S. physicians. Prev. Med. 14, 165-168
5. Steering Committee of the Physicians' Health Study Research Group (1989) Final report on the aspirin component of the ongoing Physicians' Health Study. N. Engl. J. Med. 321, 129-135
6. Greving, J.P., Buskens, E., Koffijberg, H. and Algra, A. (2008) Cost-effectiveness of aspirin treatment in the primary prevention of cardiovascular disease events in subgroups based on age, gender, and varying cardiovascular risk. Circulation 117, 2875-2883
7. Editorial (2010) Putting gender on the agenda. Nature 465, 665
8. Kim, A.M., Tingen, C.M. and Woodruff, TK. (2010) Sex bias in trials and treatment must end. Nature 465, 688-689
9. Rademaker, M. (2001) Do women have more adverse drug reactions? Am. J. Clin. Dermatol. 2, 349-351
10. Beery, A.K. and Zucker, I. (2011) Sex bias in neuroscience and biomedical research. Neurosci. Biobehav. Rev. 35, 565-572
11. Besarab, A., Bolton, W.K., Browne, J.K., Egrie, J.C., Nissenson, A.R., Okamoto, D.M., Schwab, S.J. and Goodkin, D.A. (1998) The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin. N. Engl. J. Med. 339, 584-590
12. Boaz, M., Smetana, S., Weinstein, T., Matas, Z., Gafter, U., Iaina, A., Knecht, A., Weissgarten, Y., Brunner, D., Fainaru, M. et al. (2000) Secondary prevention with antioxidants of cardiovascular disease in endstage renal disease (SPACE): randomised placebo-controlled trial. Lancet 356, 1213-1218
13. Paniagua, R., Amato, D., Vonesh, E., Correa-Rotter, R., Ramos, A., Moran, J. and Mujais, S., Mexican Nephrology Collaborative Study Group (2002) Effects of increased peritoneal clearances on mortality rates in peritoneal dialysis: ADEMEX, a prospective, randomized, controlled trial. J. Am. Soc. Nephrol. 13, 1307-1320
14. Eknoyan, G., Beck, G.J., Cheung, A.K., Daugirdas, J.T., Greene, T., Kusek, J.W., Allon, M., Bailey, J., Delmez, J.A., Depner, T.A. et al. (2002) Effect of dialysis dose and membrane flux in maintenance hemodialysis. N. Engl. J. Med. 347, 2010-2019
15. Tepel, M., van der Giet, M., Statz, M., Jankowski, J. and Zidek, W. (2003) The antioxidant acetylcysteine reduces cardiovascular events in patients with end-stage renal failure: a randomized, controlled trial. Circulation 107, 992-995
16. Wanner, C., Krane, V., März, W., Olschewski, M., Mann, J.F., Ruf, G. and Ritz, E., German Diabetes and Dialysis Study Investigators (2005) Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis. N. Engl. J. Med. 353, 238-248
17. Drueke, T.B., Locatelli, F., Clyne, N., Eckardt, K.U., Macdougall, I.C., Tsakiris, D., Burger, H.U. and Scherhag, A., CREATE Investigators (2006) Normalization of hemoglobin level in patients with chronic kidney disease and anemia. N. Engl. J. Med. 355, 2071-2084
18. Singh, A.K., Szczech, L., Tang, K.L., Barnhart, H., Sapp, S., Wolfson, M. and Reddan, D., CHOIR Investigators (2006) Correction of anemia with epoetin alfa in chronic kidney disease. N. Engl. J. Med. 355, 2085-2098
19. Jamison, R.L., Hartigan, P., Kaufman, J.S., Goldfarb, D.S., Warren, S.R., Guarino, P.D. and Gaziano, J.M., Veterans Affairs Site Investigators (2007) Effect of homocysteine lowering on mortality and vascular disease in advanced chronic kidney disease and end-stage renal disease: a randomized controlled trial. JAMA 298, 1163-1170
20. Cano, N.J., Fouque, D., Roth, H., Aparicio, M., Azar, R., Canaud, B., Chauveau, P., Combe, C., Laville, M. and Leverve, X.M., French Study Group for Nutrition in Dialysis (2007) Intradialytic parenteral nutrition does not improve survival in malnourished hemodialysis patients: a 2-year multicenter, prospective, randomized study. J. Am. Soc. Nephrol. 18, 2583-2591
21. Suki, W.N., Zabaneh, R., Cangiano, J.L., Reed, J., Fischer, D., Garrett, L., Ling, B.N., Chasan-Taber, S., Dillon, M.A., Blair, A.T. et al. (2007) Effects of sevelamer and calcium-based phosphate binders on mortality in hemodialysis patients. Kidney Int 72, 1130-1137
22. Zannad, F., Kessler, M., Lehert, P., Grunfeld, J.P., Thuilliez, C., Leizorovicz, A. and Lechat, P. (2006) Prevention of cardiovascular events in end-stage renal disease: results of a randomized trial of fosinopril and implications for future studies. Kidney Int. 70, 1318-1324
23. Locatelli, F., Martin-Malo, A., Hannedouche, T., Loureiro, A., Papadimitriou, M., Wizemann, V., Jacobson, S.H., Czekalski, S., Ronco, C. and Vanholder, R., Membrane Permeability Outcome (MPO) Study Group (2009) Effect of membrane permeability on survival of hemodialysis patients. J. Am. Soc. Nephrol. 20, 645-654
24. Fellstrom, B.C., Jardine, A.G., Schmieder, R.E., Holdaas, H., Bannister, K., Beutler, J., Chae, D.W., Chevaile, A., Cobbe, S.M., Grönhagen-Riska, C. et al., AURORA Study Group (2009) Rosuvastatin and cardiovascular events in patients undergoing hemodialysis. N. Engl. J. Med. 360, 1395-1407
25. Pfeffer, M.A., Burdmann, E.A., Chen, C.Y., Cooper, M.E., de Zeeuw, D., Eckardt, K.U., Feyzi, J.M., Ivanovich, P., Kewalramani, R., Levey, A.S. et al., TREAT Investigators (2009) A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease. N. Engl. J. Med. 361, 2019-2032
26. Cooper, B.A., Branley, P., Bulfone, L., Collins, J.F., Craig, J.C., Fraenkel, M.B., Harris, A., Johnson, D.W., Kesselhut, J., Li, J.J. et al., IDEAL study (2010) A randomized, controlled trial of early versus late initiation of dialysis. N. Engl. J. Med. 363, 609-619
27. Cice, G, Di Benedetto, A., D'Isa, S., D'Andrea, A., Marcelli, D., Gatti, E. and Calabro, R. (2010) Effects of telmisartan added to Angiotensin-converting enzyme inhibitors on mortality and morbidity in hemodialysis patients with chronic heart failure a double-blind, placebo-controlled trial. J. Am. Coll. Cardiol. 56, 1701-1708
28. Baigent, C., Landray, M.J., Reith, C., Emberson, J., Wheeler, D.C., Tomson, C., Wanner, C., Krane, V., Cass, A., Craig, J. et al., SHARP Investigators (2011) The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial. Lancet 377, 2181-2192
29. Chertow, G.M., Block, G.A., Correa-Rotter, R., Drueke, T.B., Floege, J., Goodman, W.G., Herzog, C.A., Kubo, Y., London, G.M., Mahaffey, K.W. et al., EVOLVE Trial Investigators (2012) Effect of cinacalcet on cardiovascular disease in patients undergoing dialysis. N. Engl. J. Med. 367, 2482-2494
30. Grooteman, M.P., van den Dorpel, M.A., Bots, M.L., Penne, E.L., van der Weerd, N.C., Mazairac, A.H., den Hoedt, C.H., van der Tweel, I., Levesque, R., Nube, N.J. et al., CONTRAST Investigators (2012) Effect of online hemodiafiltration on all-cause mortality and cardiovascular outcomes. J. Am. Soc. Nephrol. 23, 1087-1096
31. Johnson, D.W., Brown, F.G., Clarke, M., Boudville, N., Elias, T.J., Foo, M.W., Jones, B., Kulkarni, H., Langham, R., Ranganathan, D. et al., on behalf of the balANZ Trial Investigators (2012) Effects of biocompatible versus standard fluid on peritoneal dialysis outcomes. J. Am. Soc. Nephrol. 23, 1097-1107
32. de Zeeuw, D., Akizawa, T., Audhya, P., Bakris, G.L., Chin, M., Christ-Schmidt, H., Goldsberry, A., Houser, M., Krauth, M., Lambers Heerspink, H.J. et al. (2013) Bardoxolone methyl in type 2 diabetes and stage 4 chronic kidney disease. N. Engl. J. Med. 369, 2492-2503
33. Maduell, F., Moreso, F., Pons, M., Ramos, R., Mora-Macìa, J., Carreras, J., Soler, J., Torres, F., Campistol, J.M. and Martinez-Castelao, A., ESHOL Study Group (2013) High-efficiency postdilution online hemodiafiltration reduces all-cause mortality in hemodialysis patients. J. Am. Soc. Nephrol. 24, 487-497
34. Di Iorio, B., Molony, D., Bell, C., Cucciniello, E., Bellizzi, V., Russo, D. and Bellasi, A., INDEPENDENT Study (2013) Sevelamer versus calcium carbonate in incident hemodialysis patients: results of an open-label 24-month randomized clinical trial. Am. J. Kidney Dis. 62, 771-778
35. Ok, E., Asci, G., Toz, H., Ok, E.S., Kircelli, F., Yilmaz, M., Hur, E., Demirci, M.S., Demirci, C., Duman, S. et al., Turkish Online Haemodiafiltration Study (2013) Mortality and cardiovascular events in online haemodiafiltration (OL-HDF) compared with high-flux dialysis: results from the Turkish OL-HDF Study. Nephrol. Dial. Transplant. 28, 192-202
36. Matsumoto, Y., Mori, Y., Kageyama, S., Arihara, K., Sugiyama, T., Ohmura, H., Yakushigawa, T., Sugiyama, H., Shimada, Y., Nojima, Y. et al. (2014) Spironolactone reduces cardiovascular and cerebrovascular morbidity and mortality in hemodialysis patients. J. Am. Coll. Cardiol. 63, 528-536
37. van de Luijtgaarden, M.W., Jager, K.J., Segelmark, M., Pascual, J., Collart, F., Hemke, A.C., Remon, C., Metcalf, W., Miguel, A., Kramar, R. et al. (2015) Trends in dialysis modality choice and related patient survival in the ERA-EDTA Registry over a 20-year period. Nephrol. Dial. Transplant. 31, 120-128
38. Rathore, S.S., Wang, Y. and Krumholz, H.M. (2002) Sex-based differences in the effect of digoxin for the treatment of heart failure. N. Engl. J. Med. 347, 1403-1411
39. Kahn, S.E., Zinman, B., Lachin, J.M., Haffner, S.M., Herman, W.H., Holman, R.R., Kravitz, B.G., Yu, D., Heise, M.A., Aftring, R.P. et al. (2008) Rosiglitazone-associated fractures in type 2 diabetes: an Analysis from A Diabetes Outcome Progression Trial (ADOPT). Diabetes Care 31, 845-851
40. Sabolic, I., Asif, A.R., Budach, W.E., Wanke, C., Bahn, A. and Burckhardt, G. (2007) Gender differences in kidney function. Pflügers Arch. 455, 397-429
41. Miletic, D., Fuckar, Z., Sustic, A., Mozetic, V., Stimac, D. and Zauhar, G. (1998) Sonographic measurement of absolute and relative renal length in adults. J. Clin. Ultrasound. 26, 185-189
42. Jovanovic, D., Gasic, B., Pavlovic, S. and Naumovic, R. (2013) Correlation of kidney size with kidney function and anthropometric parameters in healthy subjects and patients with chronic kidney diseases. Ren. Fail. 35, 896-900
43. Oudar, O., Elger, M., Bankir, L., Ganten, D., Ganten, U. and Kriz, W. (1991) Differences in rat kidney morphology between males, females and testosterone-treated females. Ren. Physiol. Biochem. 14, 92-102
44. Nyengaard, J.R. and Bendtsen, T.F. (1992) Glomerular number and size in relation to age, kidney weight, and body surface in normal man. Anat. Rec. 232, 194-201
45. Munger, K. and Baylis, C. (1988) Sex differences in renal hemodynamics in rats. Am. J. Physiol. 254 2 Pt 2, F223-F231
46. Hutchens, M.P., Dunlap, J., Hurn, P.D. and Jarnberg, P.O. (2008) Renal ischemia: does sex matter? Anesth. Analg. 107, 239-249
47. Chen, K., Bi, J., Su, Y., Chappell, M.C. and Rose, J.C. (2016) Sex-specific changes in renal angiotensin-converting enzyme and angiotensin-converting enzyme 2 gene expression and enzyme activity at birth and over the first year of life. Reprod. Sci. 23, 200-210
48. Hilliard, L.M., Sampson, A.K., Brown, R.D. and Denton, K.M. (2013) The 'his and hers' of the renin-angiotensin system. Curr. Hypertens. Rep. 15, 71-79
49. Santos, R.A., Ferreira, A.J., Verano-Braga, T. and Bader, M. (2013) Angiotensin-converting enzyme 2, angiotensin-(1-7) and Mas: new players of the renin-angiotensin system. J. Endocrinol. 216, R1-R17
50. Sullivan, J.C., Rodriguez-Miguelez, P., Zimmerman, M.A. and Harris, R.A. (2015) Differences in angiotensin (1-7) between men and women. Am. J. Physiol. Heart Circ. Physiol. 308, H1171-H176
51. Quan, A., Chakravarty, S., Chen, J.K., Chen, J.C., Loleh, S., Saini, N., Harris, R.C., Capdevila, J. and Quigley, R. (2004) Androgens augment proximal tubule transport. Am. J. Physiol. Renal Physiol. 287, F452-F459
52. Quigley, R. (2008) Androgens stimulate proximal tubule transport. Gend. Med. 5 Suppl A, S114-S120
53. Sullivan, J.C. (2008) Sex and the renin-angiotensin system: inequality between the sexes in response to RAS stimulation and inhibition. Am. J. Physiol. Regul. Integr. Comp. Physiol. 294, R1220-R1226
54. Rabi, D.M., Khan, N., Vallee, M., Hladunewich, M.A., Tobe, S.W. and Pilote, L. (2008) Reporting on sex-based analysis in clinical trials of angiotensin-converting enzyme inhibitor and angiotensin receptor blocker efficacy. Can. J. Cardiol. 24, 491-496
55. Hudson, M., Rahme, E., Behlouli, H., Sheppard, R. and Pilote, L. (2007) Sex differences in the effectiveness of angiotensin receptor blockers and angiotensin converting enzyme inhibitors in patients with congestive heart failure - a population study. Eur. J. Heart Fail. 9, 602-609
56. Ruggenenti, P., Perna, A., Zoccali, C., Gherardi, G., Benini, R., Testa, A. and Remuzzi, G., Gruppo Italiano di Studi Epidemologici in Nefrologia (Gisen) (2000) Chronic proteinuric nephropathies. II. Outcomes and response to treatment in a prospective cohort of 352 patients: differences between women and men in relation to the ACE gene polymorphism. J. Am. Soc. Nephrol. 11, 88-96
57. Zapater, P., Novalbos, J., Gallego-Sandin, S., Hernandez, F.T. and Abad-Santos, F. (2004) Gender differences in angiotensin-converting enzyme (ACE) activity and inhibition by enalaprilat in healthy volunteers. J. Cardiovasc. Pharmacol. 43, 737-744
58. Miller, J.A., Cherney, D.Z., Duncan, J.A., Lai, V., Burns, K.D., Kennedy, C.R., Zimpelmann, J., Gao, W., Cattran, D.C. and Scholey, J.W. (2006) Gender differences in the renal response to renin-angiotensin system blockade. J. Am. Soc. Nephrol. 17, 2554-2560
59. Davies, D.F. and Shock, N.W. (1950) Age changes in glomerular filtration rate, effective renal plasma flow, and tubular excretory capacity in adult males. J. Clin. Invest. 29, 496-507
60. Weinstein, J.R. and Anderson, S. (2010) The aging kidney: physiological changes. Adv. Chronic Kidney Dis. 17, 302-307
61. Bolignano, D., Mattace-Raso, F., Sijbrands, E.J. and Zoccali, C. (2014) The aging kidney revisited: a systematic review. Ageing Res. Rev. 14, 65-80
62. Baylis, C. (2009) Sexual dimorphism in the aging kidney: differences in the nitric oxide system. Nat. Rev. Nephrol. 5, 384-396
63. Silbiger, S. and Neugarten, J. (2008) Gender and human chronic renal disease. Gend. Med. 5 Suppl A, S3-S10
64. Neugarten, J., Acharya, A. and Silbiger, S.R. (2000) Effect of gender on the progression of nondiabetic renal disease: a meta-analysis. J. Am. Soc. Nephrol. 11, 319-329
65. Ruggenenti, P., Gaspari, F., Perna, A. and Remuzzi, G. (1998) Cross sectional longitudinal study of spot morning urine protein:creatinine ratio, 24 hour urine protein excretion rate, glomerular filtration rate, and end stage renal failure in chronic renal disease in patients without diabetes. BMJ 316, 504-509
66. Rosman, J.B., Langer, K., Brandl, M., Piers-Becht, T.P., van der Hem, G.K., ter Wee, P.M. and Donker, A.J. (1989) Protein-restricted diets in chronic renal failure: a four year follow-up shows limited indications. Kidney Int. Suppl. 27, S96-S102
67. Coggins, C.H., Breyer Lewis, J., Caggiula, A.W., Castaldo, L.S., Klahr, S. and Wang, S.R. (1998) Differences between women and men with chronic renal disease. Nephrol. Dial. Transplant. 13, 1430-1437
68. Pscheidt, C., Nagel, G., Zitt, E., Kramar, R., Concin, H. and Lhotta, K. (2015) Sex-and time-dependent patterns in risk factors of end-stage renal disease: a large Austrian cohort with up to 20 years of follow-up. PloS One 10, e0135052
69. Dubey, R.K. and Jackson, E.K. (2001) Estrogen-induced cardiorenal protection: potential cellular, biochemical, and molecular mechanisms. Am. J. Physiol. Renal Physiol. 280, F365-F388
70. Jafar, T.H., Schmid, C.H., Stark, P.C., Toto, R., Remuzzi, G., Ruggenenti, P., Marcantoni, C., Becker, G., Shahinfar, S., De Jong, P.E. et al. (2003) The rate of progression of renal disease may not be slower in women compared with men: a patient-level meta-analysis. Nephrol. Dial. Transplant. 18, 2047-2053
71. Halbesma, N., Brantsma, A.H., Bakker, S.J., Jansen, D.F., Stolk, R.P., De Zeeuw, D., De Jong, P.E. and Gansevoort, R.T., PREVEND study group (2008) Gender differences in predictors of the decline of renal function in the general population. Kidney Int. 74, 505-512
72. Baylis, C. (2012) Sexual dimorphism: the aging kidney, involvement of nitric oxide deficiency, and angiotensin II overactivity. J. Gerontol. A Biol. Sci. Med. Sci. 67, 1365-1372
73. Sandberg, K. (2008) Mechanisms underlying sex differences in progressive renal disease. Gend. Med. 5, 10-23
74. Luksha, L., Stenvinkel, P., Hammarqvist, F., Carrero, J.J., Davidge, S.T. and Kublickiene, K. (2012) Mechanisms of endothelial dysfunction in resistance arteries from patients with end-stage renal disease. PLoS One 7, e36056
75. Pfeilschifter, J., Kunz, D. and Mühl, H. (1993) Nitric oxide: an inflammatory mediator of glomerular mesangial cells. Nephron 64, 518-525
76. Schmidt, R.J. and Baylis, C. (2000) Total nitric oxide production is low in patients with chronic renal disease. Kidney Int. 58, 1261-1266
77. Schmidt, R.J., Yokota, S., Tracy, T.S., Sorkin, M.I. and Baylis, C. (1999) Nitric oxide production is low in end-stage renal disease patients on peritoneal dialysis. Am. J. Physiol. 276 5 Pt 2, F794-F797
78. Zatz, R. and Baylis, C. (1998) Chronic nitric oxide inhibition model six years on. Hypertension 32, 958-964
79. Ji, H., Pesce, C., Zheng, W., Kim, J., Zhang, Y., Menini, S., Haywood, J.R. and Sandberg, K. (2005) Sex differences in renal injury and nitric oxide production in renal wrap hypertension. Am. J. Physiol. Heart Circ. Physiol. 288, H43-H47
80. Neugarten, J., Ding, Q., Friedman, A., Lei, J. and Silbiger, S. (1997) Sex hormones and renal nitric oxide synthases. J. Am. Soc. Nephrol. 8, 1240-1246
81. Xiao, S., Gillespie, D.G., Baylis, C., Jackson, E.K. and Dubey, R.K. (2001) Effects of estradiol and its metabolites on glomerular endothelial nitric oxide synthesis and mesangial cell growth. Hypertension 37 2 Pt 2, 645-650
82. Forte, P., Kneale, B.J., Milne, E., Chowienczyk, P.J., Johnston, A., Benjamin, N. and Ritter, J.M. (1998) Evidence for a difference in nitric oxide biosynthesis between healthy women and men. Hypertension 32, 730-734
83. Matsuda, T., Yamamoto, T., Muraguchi, A. and Saatcioglu, F. (2001) Cross-talk between transforming growth factor-beta and estrogen receptor signaling through Smad3. J. Biol. Chem. 276, 42908-42914
84. Moxley, G., Stern, A.G., Carlson, P., Estrada, E., Han, J. and Benson, LL. (2004) Premenopausal sexual dimorphism in lipopolysaccharide-stimulated production and secretion of tumor necrosis factor. J. Rheumatol. 31, 686-694
85. Ji, H., Zheng, W., Menini, S., Pesce, C., Kim, J., Wu, X., Mulroney, S.E. and Sandberg, K. (2007) Female protection in progressive renal disease is associated with estradiol attenuation of superoxide production. Gend. Med. 4, 56-71
86. Meuwese, C.L. and Carrero, J.J. (2013) Chronic kidney disease and hypothalamic-pituitary axis dysfunction: the chicken or the egg? Arch. Med. Res. 44, 591-600
87. Stringer, K.D., Komers, R., Osman, S.A., Oyama, T.T., Lindsley, J.N. and Anderson, S. (2005) Gender hormones and the progression of experimental polycystic kidney disease. Kidney Int. 68, 1729-1739
88. Elliot, S.J., Berho, M., Korach, K., Doublier, S., Lupia, E., Striker, G.E. and Karl, M. (2007) Gender-specific effects of endogenous testosterone: female alpha-estrogen receptor-deficient C57Bl/6J mice develop glomerulosclerosis. Kidney Int. 72, 464-472
89. Maric, C., Sandberg, K. and Hinojosa-Laborde, C. (2004) Glomerulosclerosis and tubulointerstitial fibrosis are attenuated with 17beta-estradiol in the aging Dahl salt sensitive rat. J. Am. Soc. Nephrol. 15, 1546-1556
90. Catanuto, P., Doublier, S., Lupia, E., Fornoni, A., Berho, M., Karl, M., Striker, G.E., Xia, X. and Elliot, S. (2009) 17β-Estradiol and tamoxifen upregulate estrogen receptor beta expression and control podocyte signaling pathways in a model of type 2 diabetes. Kidney Int. 75, 1194-11201
91. Hutchens, M.P., Fujiyoshi, T., Komers, R., Herson, P.S. and Anderson, S. (2012) Estrogen protects renal endothelial barrier function from ischemia-reperfusion in vitro and in vivo. Am. J. Physiol. Renal Physiol. 303, F377-F385
92. Ahmed, S.B., Hovind, P., Parving, H.H., Rossing, P., Price, D.A., Laffel, L.M., Lansang, M.C., Stevanovic, R., Fisher, N.D. and Hollenberg, N.K. (2005) Oral contraceptives, angiotensin-dependent renal vasoconstriction, and risk of diabetic nephropathy. Diabetes Care 28, 1988-1994
93. Agarwal, M., Selvan, V., Freedman, B.I., Liu, Y. and Wagenknecht, L.E. (2005) The relationship between albuminuria and hormone therapy in postmenopausal women. Am. J. Kidney Dis. 45, 1019-1025
94. Szekacs, B., Vajo, Z., Varbiro, S., Kakucs, R., Vaslaki, L., Acs, N., Mucsi, I. and Brinton, E.A. (2000) Postmenopausal hormone replacement improves proteinuria and impaired creatinine clearance in type 2 diabetes mellitus and hypertension. Br. J. Obstet. Gynaecol. 107, 1017-1021
95. Monster, T.B., Janssen, W.M., de Jong, P.E. and de Jong-van den Berg, L.T., Group PoRaVESDS. (2001) Oral contraceptive use and hormone replacement therapy are associated with microalbuminuria. Arch. Intern. Med. 161, 2000-2005
96. Ahmed, S.B., Culleton, B.F., Tonelli, M., Klarenbach, S.W., Macrae, J.M., Zhang, J. and Hemmelgam, B.R. (2008) Oral estrogen therapy in postmenopausal women is associated with loss of kidney function. Kidney Int. 74, 370-376
97. Schopick, E.L., Fisher, N.D., Lin, J., Forman, J.P. and Curhan, G.C. (2009) Post-menopausal hormone use and albuminuria. Nephrol. Dial. Transplant. 24, 3739-3744
98. Ji, H., Menini, S., Mok, K., Zheng, W., Pesce, C., Kim, J., Mulroney, S and Sandberg, K. (2005) Gonadal steroid regulation of renal injury in renal wrap hypertension. Am. J. Physiol. Renal Physiol. 288, F513-F520
99. Cho, M.H., Jung, K.J., Jang, H.S., Kim, J.I. and Park, K.M. (2012) Orchiectomy attenuates kidney fibrosis after ureteral obstruction by reduction of oxidative stress in mice. Am. J. Nephrol. 35, 7-16
100. Metcalfe, P.D., Leslie, J.A., Campbell, M.T., Meldrum, D.R., Hile, K.L. and Meldrum, K.K. (2008) Testosterone exacerbates obstructive renal injury by stimulating TNF-alpha production and increasing proapoptotic and profibrotic signaling. Am. J. Physiol. Endocrinol. Metab. 294, E435-E443
101. Reckelhoff, J.F., Zhang, H. and Srivastava, K. (2000) Gender differences in development of hypertension in spontaneously hypertensive rats: role of the renin-angiotensin system. Hypertension 35 1 Pt 2, 480-483
102. Yilmaz, M.I., Sonmez, A., Qureshi, A.R., Saglam, M., Stenvinkel, P., Yaman, H., Eyileten, T., Caglar, K., Oguz, Y., Talipinar, A. et al. (2011) Endogenous testosterone, endothelial dysfunction, and cardiovascular events in men with nondialysis chronic kidney disease. Clin. J. Am. Soc. Nephrol. 6, 1617-1625
103. Haring, R., Nauck, M., Völzke, H., Endlich, K., Lendeckel, U., Friedrich, N., Dorr, M., Rettig, R., Kroemer, H.A. and Wallaschofski, H. (2011) Low serum testosterone is associated with increased mortality in men with stage 3 or greater nephropathy. Am. J. Nephrol. 33, 209-217
104. Khurana, K.K., Navaneethan, S.D., Arrigain, S., Schold, J.D., Nally, J.V. and Shoskes, D.A. (2014) Serum testosterone levels and mortality in men with CKD stages. Am. J. Kidney Dis. 64, 367-374
105. Lapi, F., Azoulay, L., Niazi, M.T., Yin, H., Benayoun, S. and Suissa, S. (2013) Androgen deprivation therapy and risk of acute kidney injury in patients with prostate cancer. JAMA 310, 289-296
106. Molinari, C., Battaglia, A., Grossini, E., Mary, D.A., Vassanelli, C. and Vacca, G. (2002) The effect of testosterone on regional blood flow in prepubertal anaesthetized pigs. J. Physiol. 543 Pt 1, 365-372
107. Soljancic, A., Ruiz, A.L., Chandrashekar, K., Maranon, R., Liu, R., Reckelhoff, J.F. and Juncos, L.A. (2013) Protective role of testosterone in ischemia-reperfusion-induced acute kidney injury. Am. J. Physiol. Regul. Integr. Comp. Physiol. 304, R951-R958
108. Okada, K., Yanai, M., Takeuchi, K., Matsuyama, K., Nitta, K., Hayashi, K. and Takahashi, S. (2014) Sex differences in the prevalence, progression, and improvement of chronic kidney disease. Kidney Blood Press. Res. 39, 279-288
109. Xu, H., Wolk, A. and Carrero, J.J. (2015) Parental history of cardiovascular disease and risk of ESRD in women. Am. J. Kidney Dis. 66, 726-728
110. Huang, X., Sui, X., Ruiz, J.R., Hirth, V., Ortega, F.B., Blair, S.N. and Carrero, J.J. (2015) Parental history of premature cardiovascular disease, estimated GFR, and rate of estimated GFR decline: results from the Aerobics Center Longitudinal Study. Am. J. Kidney Dis. 65, 692-700
111. Agondi, R.F., Gallani, M.C., Rodrigues, R.C. and Cornelio, M.E. (2011) Relationship between beliefs regarding a low salt diet in chronic renal failure patients on dialysis. J. Ren. Nutr. 21, 160-168
112. Crews, D.C, Kuczmarski, M.F., Miller, E.R., Zonderman, A.B., Evans, M.K. and Powe, N.R. (2015) Dietary habits, poverty, and chronic kidney disease in an urban population. J. Ren. Nutr. 25, 103-110
113. Ellam, T., Fotheringham, J. and Kawar, B. (2014) Differential scaling of glomerular filtration rate and ingested metabolic burden: implications for gender differences in chronic kidney disease outcomes. Nephrol. Dial. Transplant. 29, 1186-1194
114. Nitsch, D. (2014) Is there a difference in metabolic burden between men and women? Nephrol. Dial. Transplant. 29, 1110-1112
115. Verhave, J.C., Hillege, H.L., Burgerhof, J.G., Navis, G., de Zeeuw, D. and de Jong, P.E. (2003) Cardiovascular risk factors are differently associated with urinary albumin excretion in men and women. J. Am. Soc. Nephrol. 14, 1330-1335
116. U.S. Renal Data System (2013) USRDS 2013 annual data report: atlas of chronic kidney disease and end-stage renal disease in the United States, national institutes of health, national institute of diabetes and digestive and kidney diseases, p. 44
117. Go, A.S., Chertow, G.M., Fan, D., McCulloch, C.E. and Hsu, C.Y. (2004) Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N. Engl. J. Med. 351, 1296-1305
118. Zhang, Q.L. and Rothenbacher, D. (2008) Prevalence of chronic kidney disease in population-based studies: systematic review. BMC Public Health 8, 117
119. Nitsch, D., Felber Dietrich, D., von Eckardstein, A., Gaspoz, J.M., Downs, S.H., Leuenberger, P., Tschopp, J.M., Brändli, O., Keller, R., Gerbase, M.W. et al. (2006) Prevalence of renal impairment and its association with cardiovascular risk factors in a general population: results of the Swiss SAPALDIA study. Nephrol. Dial. Transplant. 21, 935-944
120. Brown, W.W., Peters, R.M., Ohmit, S.E., Keane, W.F., Collins, A., Chen, S.C., King, K., Klag, M.J., Molony, D.A. and Flack, J.M. (2003) Early detection of kidney disease in community settings: the Kidney Early Evaluation Program (KEEP). Am. J. Kidney Dis. 42, 22-35
121. Chadban, S.J., Briganti, E.M., Kerr, P.G., Dunstan, D.W., Welborn, T.A., Zimmet, P.Z. and Atkins, R.C. (2003) Prevalence of kidney damage in Australian adults: the AusDiab kidney study. J. Am. Soc. Nephrol. 14 7 Suppl 2, S131-S138
122. Iseki, K., Iseki, C., Ikemiya, Y. and Fukiyama, K. (1996) Risk of developing end-stage renal disease in a cohort of mass screening. Kidney Int 49, 800-805
123. Mills, K.T., Xu, Y., Zhang, W., Bundy, J.D., Chen, C.S., Kelly, T.N., Chen, J. and He, J. (2015) A systematic analysis of worldwide population-based data on the global burden of chronic kidney disease in 2010. Kidney Int. 88, 950-957
124. Hecking, M., Bieber, B.A., Ethier, J., Kautzky-Willer, A., Sunder-Plassmann, G., Saemann, M.D., Raemirez, S.P.B., Gillespie, B.W., Pisoni, R.L., Robinson, B.M. et al. (2014) Sex-specific differences in hemodialysis prevalence and practices and the male-to-female mortality rate: the Dialysis Outcomes and Practice Patterns Study (DOPPS). PLoS Med. 11, e1001750
125. Stevens, L.A., Coresh, J., Greene, T. and Levey, A.S. (2006) Assessing kidney function - measured and estimated glomerular filtration rate. N. Engl. J. Med. 354, 2473-2483
126. Levey, A.S, Coresh, J., Greene, T., Stevens, L.A., Zhang, Y.L., Hendriksen, S., Kusek, J.W. and Van Lente, F. (2006) Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann. Intern. Med. 145, 247-254
127. Froissart, M., Rossert, J., Jacquot, C., Paillard, M. and Houillier, P. (2005) Predictive performance of the modification of diet in renal disease and Cockcroft-Gault equations for estimating renal function. J. Am. Soc. Nephrol. 16, 763-773
128. Li, Y., Kapke, A., Jin, Y., Pearson, J., Port, F.K. and Robinson, B. (2013) Estimated GFR at dialysis initiation: associations with clinical and non-clinical factors. J. Am. Soc. Nephrol. 24, 745A (abstract SA-PO516)
129. Nitsch, D., Grams, M., Sang, Y., Black, C., Cirillo, M., Djurdjev, O., Iseki, K., Jassal, S.K., Kimm, H., Kronenberg, F. et al. (2013) Associations of estimated glomerular filtration rate and albuminuria with mortality and renal failure by sex: a meta-analysis. BMJ 346, f324
130. Turin, T.C., Tonelli, M., Manns, B.J., Ravani, P., Ahmed, S.B. and Hemmelgarn, B.R. (2012) Chronic kidney disease and life expectancy. Nephrol. Dial. Transplant. 27, 3182-3186
131. Coresh, J., Byrd-Holt, D., Astor, B.C., Briggs, J.P., Eggers, P.W., Lacher, D.A. and Hostetter, T.H. (2005) Chronic kidney disease awareness, prevalence, and trends among U. S. adults, 1999 to 2000. J. Am. Soc. Nephrol. 16, 180-188
132. Kausz, A.T., Obrador, G.T., Arora, P., Ruthazer, R., Levey, A.S. and Pereira, B.J. (2000) Late initiation of dialysis among women and ethnic minorities in the United States. J. Am. Soc. Nephrol. 11, 2351-2357
133. Carrero, J.J., de Jager, D.J., Verduijn, M., Ravani, P., De Meester, J., Heaf, J.G., Finne, P., Hoitsma, A.J., Pascual, J., Jarraya, F. et al. (2011) Cardiovascular and noncardiovascular mortality among men and women starting dialysis. Clin. J. Am. Soc. Nephrol. 6, 1722-1730
134. Villar, E., Remontet, L., Labeeuw, M. and Ecochard, R. (2007) Effect of age, gender, and diabetes on excess death in end-stage renal failure. J. Am. Soc. Nephrol. 18, 2125-2134
135. Oien, C.M., Reisaeter, A.V., Os, I., Jardine, A., Fellstrom, B. and Holdaas, H. (2006) Gender-associated risk factors for cardiac end points and total mortality after renal transplantation: post hoc analysis of the ALERT study. Clin. Transplant. 20, 374-382
136. Carrero, J.J., de Mutsert, R., Axelsson, J., Dekkers, O.M., Jager, K.J., Boeschoten, E.W., Krediet, R.T. and Dekker, F.W., the NECOSAD Study Group (2011) Sex differences in the impact of diabetes on mortality in chronic dialysis patients. Nephrol. Dial. Transplant. 26, 270-276
137. Foley, R.N., Curtis, B.M., Randell, E.W. and Parfrey, P.S. (2010) Left ventricular hypertrophy in new hemodialysis patients without symptomatic cardiac disease. Clin. J. Am. Soc. Nephrol. 5, 805-813
138. Malberti, F., Marcelli, D., Conte, F., Limido, A., Spotti, D. and Locatelli, F. (2001) Parathyroidectomy in patients on renal replacement therapy: an epidemiologic study. J. Am. Soc. Nephrol. 12, 1242-1248
139. Schlieper, G., Brandenburg, V., Djuric, Z., Damjanovic, T., Markovic, N., Schurgers, L., Krüger, T., Westenfeld, R., Ackermann, D., Haselhuhn, A. et al. (2009) Risk factors for cardiovascular calcifications in non-diabetic Caucasian haemodialysis patients. Kidney Blood Press. Res. 32, 161-168
140. Ros, S., Remon, C., Qureshi, A.R., Quiros, P., Lindholm, B. and Carrero, J.J. (2013) Increased risk of fatal infections in women starting peritoneal dialysis. Perit. Dial. Int. 33, 487-494
141. Vogelzang, J.L., van Stralen, K.J., Noordzij, M., Diez, J.A., Carrero, J.J., Couchoud, C., Dekker, F.W., Finne, P., Fouque, D., Heaf, J.G. et al. (2015) Mortality from infections and malignancies in patients treated with renal replacement therapy: data from the ERA-EDTA registry. Nephrol. Dial. Transplant. 30, 1028-1037
142. Kato, S., Chmielewski, M., Honda, H., Pecoits-Filho, R., Matsuo, S., Yuzawa, Y., Tranaeus, A., Steinvinkel, P. and Lindholm, B. (2008) Aspects of immune dysfunction in end-stage renal disease. Clin. J. Am. Soc. Nephrol. 3, 1526-1533
143. Raju, R., Bland, K.I. and Chaudry, I.H. (2008) Estrogen: a novel therapeutic adjunct for the treatment of trauma-hemorrhage-induced immunological alterations. Mol. Med. 14, 213-221
144. Filocamo, M.T., Zanazzi, M., Li, Marzi, V., Lombardi, G., Del Popolo, G., Mancini, G., Salvadori, M. and Nicita, G. (2009) Sexual dysfunction in women during dialysis and after renal transplantation. J. Sex. Med. 6, 3125-3131
145. Matuszkiewicz-Rowinska, J., Skorzewska, K., Radowicki, S., Sokalski, A., Przedlacki, J., Niemczyk, S., Wlodarczyk, D., Puka, J. and Switalski, M. (1999) The benefits of hormone replacement therapy in pre-menopausal women with oestrogen deficiency on haemodialysis. Nephrol. Dial. Transplant. 14, 1238-1243
146. O'Shaughnessy, M.M., Montez-Rath, M.E., Lafayette, R.A. and Winkelmayer, W.C. (2015) Patient characteristics and outcomes by GN subtype in ESRD. Clin. J. Am. Soc. Nephrol. 10, 1170-1178
147. Hecking, M., Bieber, B.A., Ethier, J., Kautzky-Willer, A., Sunder-Plassmann, G., Säemann, M.D., Ramirez, S.P., Gillespie, B.W., Pisoni, R.L., Robinson, B.M. et al. (2014) Sex-specific differences in hemodialysis prevalence and practices and the male-to-female mortality rate: the Dialysis Outcomes and Practice Patterns Study (DOPPS). PLoS Med. 11, e1001750
148. Yu, M.K., Katon, W. and Young, B.A. (2015) Associations between sex and incident chronic kidney disease in a prospective diabetic cohort. Nephrology 20, 451-458
149. Yang, C.C., Chen, T.C., Wu, C.S., Cheng, B.C., Lam, K.K., Chien, Y.S., Chuang, F.R. and Lee, C.T. (2010) Sex differences in kidney size and clinical features of patients with uremia. Gend. Med. 7, 451-457
150. Huxley, R., Barzi, F. and Woodward, M. (2006) Excess risk of fatal coronary heart disease associated with diabetes in men and women: meta-analysis of 37 prospective cohort studies. BMJ (Clin. Res.) 332, 73-78
151. Yusuf, S., Hawken, S., Ounpuu, S., Dans, T., Avezum, A., Lanas, F., McQueen, M., Budaj, A., Pais, P., Varigos, J. et al., INTERHEART Study Investigators (2004) Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 364, 937-952
152. Flink, L., Mochari-Greenberger, H. and Mosca, L. (2013) Gender differences in clinical outcomes among diabetic patients hospitalized for cardiovascular disease. Am. Heart J. 165, 972-978
153. Szalat, A. and Raz, I. (2008) Gender-specific care of diabetes mellitus: particular considerations in the management of diabetic women. Diabetes Obes. Metab. 10, 1135-1156
154. Stenvinkel, P., Carrero, J.J., von Walden, F., Ikizler, T.A. and Nader, G.A. (2015) Muscle wasting in end-stage renal disease promulgates premature death: established, emerging and potential novel treatment strategies. Nephrol. Dial. Transplant. doi: 10.1093/ndt/gfv122
155. Carrero, J.J., Chmielewski, M., Axelsson, J., Snaedal, S., Heimburger, O., Barany, P., Suliman, M.E., Lindholm, B., Stenvinkel, P. and Qureshi, A.R. (2008) Muscle atrophy, inflammation and clinical outcome in incident and prevalent dialysis patients. Clin. Nutr. 27, 557-564
156. Stenvinkel, P., Wanner, C., Metzger, T., Heimburger, O., Mallamaci, F., Tripepi, G., Malatino, L. and Zoccali, C. (2002) Inflammation and outcome in end-stage renal failure: does female gender constitute a survival advantage? Kidney Int. 62, 1791-1798
157. Meuwese, C.L., Stenvinkel, P., Dekker, F.W. and Carrero, J.J. (2011) Monitoring of inflammation in patients on dialysis: forewarned is forearmed. Nat. Rev. Nephrol. 7, 166-176
158. Carrero, J.J., Qureshi, A.R., Axelsson, J., Avesani, C.M., Suliman, M.E., Kato, S., Barany, P., Snaedal-Jonsdottir, S., Alvestrand, A., Heimbürger, O. et al. (2007) Comparison of nutritional and inflammatory markers in dialysis patients with reduced appetite. Am. J. Clin. Nutr. 85, 695-701
159. Stenvinkel, P., Barany, P., Chung, S.H., Lindholm, B. and Heimburger, O. (2002) A comparative analysis of nutritional parameters as predictors of outcome in male and female ESRD patients. Nephrol. Dial. Transplant. 17, 1266-1274
160. Carrero, J.J., Cordeiro, A.C., Lindholm, B. and Stenvinkel, P. (2010) The emerging pleiotrophic role of adipokines in the uremic phenotype. Curr. Opin. Nephrol. Hypertens. 19, 37-42
161. Ho, L.T. and Sprague, S.M. (2013) Women and CKD-mineral and bone disorder. Adv. Chronic Kidney Dis. 20, 423-426
162. Tonelli, M., Sacks, F., Pfeffer, M., Gao, Z. and Curhan, G., Investigators CARET (2005) Relation between serum phosphate level and cardiovascular event rate in people with coronary disease. Circulation 112, 2627-2633
163. Onufrak, S.J., Bellasi, A., Cardarelli, F., Vaccarino, V., Muntner, P., Shaw, L.J. and Raggi, P. (2009) Investigation of gender heterogeneity in the associations of serum phosphorus with incident coronary artery disease and all-cause mortality. Am. J. Epidemiol. 169, 67-77
164. Martin, M., Valls, J., Betriu, A., Fernandez, E. and Valdivielso, J.M. (2015) Association of serum phosphorus with subclinical atherosclerosis in chronic kidney disease. Sex makes a difference. Atherosclerosis 241, 264-270
165. Saab, G., Whooley, M.A., Schiller, N.B. and Ix, J.H. (2010) Association of serum phosphorus with left ventricular mass in men and women with stable cardiovascular disease: data from the Heart and Soul Study. Am. J. Kidney Dis. 56, 496-505
166. Yoo, K.D., Kang, S., Choi, Y., Yang, S.H., Heo, N.J., Chin, H.J., Oh, K.H., Joo, K.W., Kim, Y.S. and Lee, H. (2016) Sex, age, and the association of serum phosphorus with all-cause mortality in adults with normal kidney function. Am. J. Kidney Dis. 67, 79-88
167. Ferrucci, L, Maggio, M, Bandinelli, S., Basaria, S., Lauretani, F., Ble, A., Valenti, G., Ershire, W.B., Gurainik, J.M. and Longo, D.L. (2006) Low testosterone levels and the risk of anemia in older men and women. Arch. Intern. Med. 166, 1380-1388
168. Locatelli, F., Nissenson, A.R., Barrett, B.J., Walker, R.G., Wheeler, D.C., Eckardt, K.U., Lameire, N.H. and Eknoyan, G. (2008) Clinical practice guidelines for anemia in chronic kidney disease: problems and solutions. A position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int. 74, 1237-1240
169. Ifudu, O. (2002) Patient characteristics determining rHuEPO dose requirements. Nephrol. Dial. Transplant. 17 Suppl 5, 38-41
170. Frankenfield, D.L., Rocco, M.V., Frederick, P.R., Pugh, J., McClellan, W.M. and Owen, W.F. (1999) Racial/ethnic analysis of selected intermediate outcomes for hemodialysis patients: results from the 1997 ESRD Core Indicators Project. Am. J. Kidney Dis. 34, 721-730
171. Madore, F., Lowrie, E.G., Brugnara, C., Lew, N.L., Lazarus, J.M., Bridges, K. and Owen, W.F. (1997) Anemia in hemodialysis patients: variables affecting this outcome predictor. J. Am. Soc. Nephrol. 8, 1921-1929
172. Hsu, C.Y., Bates, D.W., Kuperman, G.J. and Curhan, G.C. (2001) Relationship between hematocrit and renal function in men and women. Kidney Int. 59, 725-731
173. Hsu, C.Y., McCulloch, C.E. and Curhan, G.C. (2002) Epidemiology of anemia associated with chronic renal insufficiency among adults in the United States: results from the Third National Health and Nutrition Examination Survey. J. Am. Soc. Nephrol. 13, 504-510
174. Ifudu, O., Uribarri, J., Rajwani, I., Vlacich, V., Reydel, K., Delosreyes, G. and Friedman, E.A. (2001) Gender modulates responsiveness to recombinant erythropoietin. Am. J. Kidney Dis. 38, 518-522
175. Bae, M.N., Kim, S.H., Kim, Y.O., Jin, D.C., Song, H.C., Choi, E.J., Kim, Y.-L., Kim, Y.-S., Kang, S.-W., Kim, N.-H. et al. (2015) Association of erythropoietin-stimulating agent responsiveness with mortality in hemodialysis and peritoneal dialysis patients. PLoS One 10, e0143348
176. Suttorp, M.M., Hoekstra, T., Rotmans, J.I., Ott, I., Mittelman, M., Krediet, R.T. and Dekker, F.W. (2013) Erythropoiesis-stimulating agent resistance and mortality in hemodialysis and peritoneal dialysis patients. BMC Nephrol. 14, 200
177. Duncan, J.A. and Levin, A. (2005) Sex, haemoglobin and kidney disease: new perspectives. Eur. J. Clin. Invest. 35 Suppl 3, 52-57
178. Ros, S. and Carrero, J.J. (2013) Endocrine alterations and cardiovascular risk in CKD: is there a link? Nefrologia 33, 181-187
179. Iglesias, P., Carrero, J.J. and Diez, J.J. (2012) Gonadal dysfunction in men with chronic kidney disease: clinical features, prognostic implications and therapeutic options. J. Nephrol. 25, 31-42
180. Yavuz, D., Topcu, G., Ozener, C., Akalin, S. and Sirikci, O. (2005) Macroprolactin does not contribute to elevated levels of prolactin in patients on renal replacement therapy. Clin. Endocrinol. 63, 520-524
181. Veldhuis, J.D., Iranmanesh, A., Wilkowski, M.J. and Samojlik, E. (1994) Neuroendocrine alterations in the somatotropic and lactotropic axes in uremic men. Eur. J. Endocrinol. 131, 489-498
182. Carrero, J.J., Kyriazis, J., Sonmez, A., Tzanakis, I., Qureshi, A.R., Stenvinkel, P., Saglam, M., Stylianou, K., Yaman, H., Taslipinar, A. et al. (2012) Prolactin levels, endothelial dysfunction, and the risk of cardiovascular events and mortality in patients with CKD. Clin. J. Am. Soc. Nephrol. 7, 207-215
183. Francis, K., Lewis, B.M., Akatsu, H., Monk, P.N., Cain, S.A., Scanlon, M.F., Morgan, B.P., Ham, J. and Gasque, P. (2003) Complement C3a receptors in the pituitary gland: a novel pathway by which an innate immune molecule releases hormones involved in the control of inflammation. FASEB J. 17, 2266-2268
184. Sauro, M.D., Buckley, A.R., Russell, D.H. and Fitzpatrick, D.F. (1989) Prolactin stimulation of protein kinase C activity in rat aortic smooth muscle. Life Sci. 44, 1787-1792
185. Aziz, M.M., Ishihara, S., Rumi, M.A., Mishima, Y., Oshima, N., Kadota, C., Moriyama, I., Li, Y.Y., Rahman, F.B., Otani, A. et al. (2008) Prolactin induces MFG-E8 production in macrophages via transcription factor C/EBPbeta-dependent pathway. Apoptosis 13, 609-620
186. Bresson, J.L., Jeay, S., Gagnerault, M.C., Kayser, C., Beressi, N. and Wu, Z. (1999) Growth hormone (GH) and prolactin receptors in human peripheral blood mononuclear cells: relation with age and GH-binding protein. Endocrinology 140, 3203-3209
187. Sun, R., Li, A.L., Wei, H.M. and Tian, Z.G. (2004) Expression of prolactin receptor and response to prolactin stimulation of human NK cell lines. Cell Res. 14, 67-73
188. Carrero, J.J and Stenvinkel, P. (2012) The vulnerable man: impact of testosterone deficiency on the uraemic phenotype. Nephrol. Dial. Transplant. 27, 4030-4041
189. Carrero, J.J., Qureshi, A.R., Parini, P., Arver, S., Lindholm, B., Barany, P., Heimbürger, O. and Stenvinkel, P. (2009) Low serum testosterone increases mortality risk among male dialysis patients. J. Am. Soc. Nephrol. 20, 613-620
190. Carrero, J.J., Barany, P., Yilmaz, M.I., Qureshi, A.R., Sonmez, A., Heimburger, O., Ozgurtas, T., Yenicesu, M., Lindholm, B. and Stenvinkel, P. (2012) Testosterone deficiency is a cause of anaemia and reduced responsiveness to erythropoiesis-stimulating agents in men with chronic kidney disease. Nephrol. Dial. Transplant. 27, 709-715
191. Bello, A.K., Stenvinkel, P., Lin, M., Hemmelgarn, B., Thadhani, R., Klarenbach, S., Chan, C., Zimmerman, D., Cembrowski, G., Strippoli, G. et al. (2014) Serum testosterone levels and clinical outcomes in male hemodialysis patients. Am. J. Kidney Dis. 63, 268-275
192. Cigarran, S., Pousa, M., Castro, M.J., Gonzalez, B., Martinez, A., Barril, G., Aguilera, A., Coronel, F., Stenvinkel, P. and Carrero, J.J. (2013) Endogenous testosterone, muscle strength, and fat-free mass in men with chronic kidney disease. J. Ren. Nutr. 23, e89-e95
193. Carrero, J.J. (2014) Testosterone deficiency at the crossroads of cardiometabolic complications in CKD. Am. J. Kidney Dis. 64, 322-325
194. Cheung, K.L., Stefanick, M.L., Allison, M.A., LeBlanc, E.S., Vitolins, M.Z., Shara, N., Chertow, G.M., Winkelmayer, W.C. and Kurella Tamura, M. (2015) Menopausal symptoms in women with chronic kidney disease. Menopause 22, 1006-1011
195. Weisinger, J.R. and Bellorin-Font, E. (2004) Outcomes associated with hypogonadism in women with chronic kidney disease. Adv. Chronic Kidney Dis. 11, 361-370
196. Rossouw, J.E., Anderson, G.L., Prentice, R.L., LaCroix, A.Z., Kooperberg, C., Stefanick, M.L., Jackson, R.D., Beresford, S.A., Howard, B.V., Johnson, K.C. et al., for the Women's Health Initiative Investigators (2002) Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA 288, 321-333
197. Stehman-Breen, C., Anderson, G., Gibson, D., Kausz, A.T. and Ott, S. (2003) Pharmacokinetics of oral micronized beta-estradiol in postmenopausal women receiving maintenance hemodialysis. Kidney Int. 64, 290-294
198. Anderson, G.D. and Odegard, P.S. (2004) Pharmacokinetics of estrogen and progesterone in chronic kidney disease. Adv. Chronic Kidney Dis. 11, 357-360
199. Lew, S.Q. and Patel, S.S. (2007) Psychosocial and quality of life issues in women with end-stage renal disease. Adv. Chronic Kidney Dis. 14, 358-363
200. Yeh, S.-C., Huang, C.-H., Chou, H.-C. and Wan, T.H. (2009) Gender differences in stress and coping among elderly patients on hemodialysis. Sex Roles 60 1-2, 44-56
201. Lindqvist, R., Carlsson, M. and Sjoden, P.O. (1998) Coping strategies and quality of life among patients on hemodialysis and continuous ambulatory peritoneal dialysis. Scand. J. Caring Sci. 12, 223-230
202. Yeh, S.C. and Chou, H.C. (2007) Coping strategies and stressors in patients with hemodialysis. Psychosom. Med. 69, 182-190
203. Peng, Y.S., Huang, J.W., Hung, K.Y., Lin, B.S., Lin, C.Y., Yang, C.S., Chen, T.W., Hsia, C.C., Chen, D.L., Hsu, W.D. et al. (2013) Women on hemodialysis have lower self-reported health-related quality of life scores but better survival than men. J. Nephrol. 26, 366-374
204. Kimmel, P.L. and Patel, S.S. (2003) Psychosocial issues in women with renal disease. Adv. Ren. Replace. Ther. 10, 61-70
205. Lopes, G.B., Matos, C.M., Leite, E.B., Martins, M.T., Martins, M.S., Silva, L.F., Robinson, B.M., Port, F.K., James, S.A. and Lopes, A.A. (2010) Depression as a potential explanation for gender differences in health-related quality of life among patients on maintenance hemodialysis. Nephron Clin. Pract. 115, c35-c40
206. Takaki, J. and Yano, E. (2006) Possible gender differences in the relationships of self-efficacy and the internal locus of control with compliance in hemodialysis patients. Behav. Med. 32, 5-11
207. Devins, G.M., Hunsley, J., Mandin, H., Taub, K.J. and Paul, L.C. (1997) The marital context of end-stage renal disease: illness intrusiveness and perceived changes in family environment. Ann Behav. Med. 19, 325-332
208. Kimmel, P.L., Peterson, R.A., Weihs, K.L., Shidler, N., Simmens, S.J., Alleyne, S., Cruz, I., Yanovski, J.A., Veis, J.H. and Phillips, T.M. (2000) Dyadic relationship conflict, gender, and mortality in urban hemodialysis patients. J. Am. Soc. Nephrol. 11, 1518-1525
209. Kaveh, K. and Kimmel, P.L. (2001) Compliance in hemodialysis patients: multidimensional measures in search of a gold standard. Am. J. Kidney Dis. 37, 244-266
210. Leggat, J.E., Orzol, S.M., Hulbert-Shearon, T.E., Golper, T.A., Jones, C.A., Held, P.J. and Port, F.K. (1998) Noncompliance in hemodialysis: predictors and survival analysis. Am. J. Kidney Dis. 32, 139-145
211. Anderson, G.D. (2008) Gender differences in pharmacological response. Int. Rev. Neurobiol. 83, 1-10
212. Spalding, E.M., Chandna, S.M., Davenport, A. and Farrington, K. (2008) Kt/V underestimates the hemodialysis dose in women and small men. Kidney Int. 74, 348-355
213. Daugirdas, J.T., Depner, T.A., Greene, T., Kuhlmann, M.K., Levin, N.W., Chertow, G.M. and Rocco, M.V. (2008) Surface-area-normalized Kt/V: a method of rescaling dialysis dose to body surface area-implications for different-size patients by gender. Semin. Dial. 21, 415-421
214. Depner, T., Daugirdas, J., Greene, T., Allon, M., Beck, G., Chumlea, C., Delmez, J., Gotch, F., Kusek, J., Levin, N. et al. (2004) Dialysis dose and the effect of gender and body size on outcome in the HEMO Study. Kidney Int. 65, 1386-1394
215. Port, F.K., Wolfe, R.A., Hulbert-Shearon, T.E., McCullough, K.P., Ashby, V.B. and Held, P.J. (2004) High dialysis dose is associated with lower mortality among women but not among men. Am. J. Kidney Dis. 43, 1014-1023
216. Daugirdas, J.T., Greene, T., Chertow, G.M. and Depner, T.A. (2010) Can rescaling dose of dialysis to body surface area in the HEMO study explain the different responses to dose in women versus men? Clin. J. Am. Soc. Nephrol. 5, 1628-1636
217. Couchoud, C., Kooman, J., Finne, P., Leivestad, T., Stojceva-Taneva, O., Ponikvar, J.B., Collart, F., Kramar, R., de Francisco, A. and Jager, K.J., on behalf of the QUEST working group on dialysis adequacy (2009) From registry data collection to international comparisons: examples of haemodialysis duration and frequency. Nephrol. Dial. Transplant. 24, 217-224
218. Miller, J.E., Kovesdy, C.P., Nissenson, A.R., Mehrotra, R., Streja, E., Van Wyck, D., Greenland, S. and Kalantar-Zadeh, K. (2010) Association of hemodialysis treatment time and dose with mortality and the role of race and sex. Am. J. Kidney Dis. 55, 100-112
219. Miller, C.D., Robbin, M.L. and Allon, M. (2003) Gender differences in outcomes of arteriovenous fistulas in hemodialysis patients. Kidney Int. 63, 346-352
220. Tokars, J.I., Light, P., Anderson, J., Miller, E.R., Parrish, J., Armistead, N., Jarvis, W.R. and Gehr, T. (2001) A prospective study of vascular access infections at seven outpatient hemodialysis centers. Am. J. Kidney Dis. 37, 1232-40
221. Caplin, N., Sedlacek, M., Teodorescu, V., Falk, A. and Uribarri, J. (2003) Venous access: women are equal. Am. J. Kidney Dis. 41, 429-432
222. Shenoy, S. (2009) Surgical anatomy of upper arm: what is needed for AVF planning. J. Vasc. Access 10, 223-232
223. Saran, R., Elder, S.J., Goodkin, D.A., Akiba, T., Ethier, J., Rayner, H.C., Saito, A., Young, E.W., Gillespie, B.W., Merion, R.M. et al. (2008) Enhanced training in vascular access creation predicts arteriovenous fistula placement and patency in hemodialysis patients: results from the Dialysis Outcomes and Practice Patterns Study. Ann. Surg. 247, 885-891
224. Wasse, H., Hopson, S.D. and McClellan, W. (2010) Racial and gender differences in arteriovenous fistula use among incident hemodialysis patients. Am. J. Nephrol. 32, 234-241
225. Johansen, K.L., Sakkas, G.K., Doyle, J., Shubert, T. and Dudley, R.A. (2003) Exercise counseling practices among nephrologists caring for patients on dialysis. Am. J. Kidney Dis. 41, 171-178